Sinobiomed Inc. (SOBM/SOBM.OB) Wrap Up:

Sinobiomed, Inc., through its subsidiaries, engages in the research, development, testing, and evaluation of genetic engineered recombinant protein drugs and vaccines. Its products respond to a range of diseases, including malaria and hepatitis. The company’s products include Wanferon/Wanferin, a recombinant human interferon for treating hepatitis B hepatitis C, viral infections, and other conditions; Leflunomide, a drug for the treatment of rheumatoid arthritis; and Recombinant Acidic Fibroblast Growth Factor, a patented bio-product that treats diabetic ulcers and burns, and supports recovery from plastic surgery. Its products in clinical trials include Recombinant Malaria Vaccine; Recombin...